At a glance
ClinicalIndex Comparison RecordN/ACompleted· 55 enrolled
Drug / intervention
Image-Guided Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase I Study of Accelerated Hypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-IV Non-Small Cell Lung Cancer and Poor Performance Status
University of Texas Southwestern Medical Center·interventional·Posted Aug 9, 2018·Updated May 4, 2021
In Brief
A clinical study evaluating Image-Guided Radiation Therapy for Non-small Cell Lung Cancer. Completed, enrolled 55 participants.
Detailed Summary
The study is designed to determine whether daily image guidance and motion assessment/control will allow treatment of poor performance status patients with stage II-IV NSCLC, who would benefit from local therapy, with an accelerated course of hypofractionated radiation therapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon-small Cell Lung Cancer
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
Primary CompletionNov 2012
Study CompletionFeb 2018
First PostedAug 2018
TodayJul 2026
First PostedAug 9, 2018
Enrollment StartOct 5, 2009
Primary CompletionNov 2, 2012
Study CompletionFeb 10, 2018
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 7.9 years ago
Interventions
Image-Guided Radiation Therapyradiation
Radiotherapy to a potent tumorcidal dose